secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spero Therapeutics, Inc. (SPRO)
CIK:        0001701108
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001193125-24-082060
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Spero Therapeutics sets 2024 Annual Meeting for May 29, 2024 (online)
---------------------------------------------------------------------

- Annual Meeting on May 29, 2024, will be held entirely online via virtual format.
- Meeting scheduled more than 30 days before prior year's meeting (Oct 5, 2023), triggering special notice under Bylaws.
- Stockholders should review Bylaws for deadlines on Rule 14a-8 proposals and director nominations.
- Proxy statement will detail online attendance, voting, and question submission procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524082060/0001193125-24-082060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524082060/d818262d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-082060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer